Fortive Reports Strong Second Quarter 2022 Results; Raises Full Year 2022 Outlook
Fortive (FTV) reported robust Q2 2022 financial results, achieving 11% revenue growth year-over-year, totaling $1.46 billion. Core revenue rose by 9%, demonstrating effective mitigation of COVID-related impacts, particularly from the Shanghai lockdown. Adjusted diluted EPS increased by 18% to $0.78. The company narrowed its full-year revenue forecast to $5.78-$5.83 billion and raised core growth outlook to 8-9.5%. Notably, Fortive recorded a $16.2 million charge due to exiting the Russian market, but continued to see strong demand in workflow solutions.
- 11% year-over-year revenue growth to $1.46 billion.
- Core revenue growth of 9%, reflecting strong demand.
- 18% increase in adjusted diluted EPS to $0.78.
- Full-year revenue outlook narrowed to $5.78-$5.83 billion.
- Core growth outlook raised to 8-9.5%.
- Recorded a $16.2 million charge from exiting the Russian market.
- Delivered outstanding financial performance despite continued COVID, supply chain and foreign exchange headwinds
-
Q2 revenue growth of
11% , up9% core, ahead of expectations, reflects effective mitigation of expectedShanghai lockdown impact - Continued demand for workflow solutions yields high single-digit hardware orders and software annual recurring revenue growth in Q2
-
Flat Q2 GAAP diluted net earnings per share, up
18% adjusted diluted earnings per share -
Narrows full-year 2022 revenue growth to 10
-11% , raises core growth outlook to 8-9.5% ; narrows and raises GAAP EPS range to , and Adjusted EPS of$2.03 -$2.09 , Up 12$3.07 -$3.13 -14%
For the second quarter, net earnings from continuing operations were
For the second quarter, revenues from continuing operations increased
For the third quarter of 2022,
For the full year 2022,
The conference call can be accessed by dialing 888-440-6928 within the
ABOUT
VONTIER SEPARATION
On
As the Separation occurred during the fourth fiscal quarter of 2020,
NON-GAAP FINANCIAL MEASURES
In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings release also references “adjusted net earnings,” “adjusted diluted net earnings per share,” “free cash flow,” and “core revenue growth,” which are non-GAAP financial measures. The reasons why we believe these measures, when used in conjunction with the GAAP financial measures, provide useful information to investors, how management uses such non-GAAP financial measures, a reconciliation of these measures to the most directly comparable GAAP measures and other information relating to these measures are included in the supplemental reconciliation schedule attached. The non-GAAP financial measures should not be considered in isolation or as a substitute for the GAAP financial measures, but should instead be read in conjunction with the GAAP financial measures. The non-GAAP financial measures used by
FORWARD-LOOKING STATEMENTS
Statements in this release that are not strictly historical, including statements regarding the impact of the COVID-19 pandemic, business and acquisition opportunities, impact of acquisitions and dispositions, leadership succession, anticipated financial results, economic conditions, industry trends, future prospects, shareholder value, and any other statements identified by their use of words like “anticipate,” “expect,” “believe,” “outlook,” “guidance,” or “will” or other words of similar meaning are “forward-looking” statements within the meaning of the federal securities laws. These factors include, among other things: the duration and impact of the COVID-19 pandemic, including government-mandated mitigation efforts, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, deterioration of or instability in the economy, the markets we serve, international trade policies and the financial markets, changes in trade relations with
FORTIVE CORPORATION AND SUBSIDIARIES |
||||||||||||||||
CONSOLIDATED STATEMENTS OF EARNINGS |
||||||||||||||||
(unaudited) |
||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Sales |
|
1,463.3 |
|
|
|
1,319.7 |
|
|
|
2,839.8 |
|
|
$ |
2,578.9 |
|
|
Cost of Sales |
|
(629.8 |
) |
|
|
(564.2 |
) |
|
|
(1,214.3 |
) |
|
|
(1,111.5 |
) |
|
Gross profit |
|
833.5 |
|
|
|
755.5 |
|
|
|
1,625.5 |
|
|
|
1,467.4 |
|
|
Operating costs: |
|
|
|
|
|
|
|
|||||||||
Selling, general and administrative expenses |
|
(484.9 |
) |
|
|
(456.4 |
) |
|
|
(965.5 |
) |
|
|
(884.5 |
) |
|
Research and development expenses |
|
(100.1 |
) |
|
|
(87.8 |
) |
|
|
(199.2 |
) |
|
|
(174.0 |
) |
|
|
|
(16.2 |
) |
|
|
— |
|
|
|
(16.2 |
) |
|
|
— |
|
|
Operating profit |
|
232.3 |
|
|
|
211.3 |
|
|
|
444.6 |
|
|
|
408.9 |
|
|
Non-operating income (expense), net: |
|
|
|
|
|
|
|
|||||||||
Interest expense, net |
|
(21.0 |
) |
|
|
(25.2 |
) |
|
|
(39.8 |
) |
|
|
(52.9 |
) |
|
Loss on extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(104.9 |
) |
|
Gain on investment in Vontier Corporation |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
57.0 |
|
|
Gain on litigation resolution |
|
— |
|
|
|
26.0 |
|
|
|
— |
|
|
|
26.0 |
|
|
Other non-operating expense, net |
|
(3.1 |
) |
|
|
(4.6 |
) |
|
|
(5.8 |
) |
|
|
(7.9 |
) |
|
Earnings from continuing operations before income taxes |
|
208.2 |
|
|
|
207.5 |
|
|
|
399.0 |
|
|
|
326.2 |
|
|
Income taxes |
|
(35.2 |
) |
|
|
(25.5 |
) |
|
|
(60.9 |
) |
|
|
(32.5 |
) |
|
Net earnings from continuing operations |
|
173.0 |
|
|
|
182.0 |
|
|
|
338.1 |
|
|
|
293.7 |
|
|
Earnings (loss) from discontinued operations, net of income taxes |
|
— |
|
|
|
(1.1 |
) |
|
|
— |
|
|
|
(2.6 |
) |
|
Net earnings |
|
173.0 |
|
|
|
180.9 |
|
|
|
338.1 |
|
|
|
291.1 |
|
|
Mandatory convertible preferred dividends |
|
— |
|
|
|
(17.2 |
) |
|
|
— |
|
|
|
(34.5 |
) |
|
Net earnings attributable to common stockholders |
$ |
173.0 |
|
|
$ |
163.7 |
|
|
$ |
338.1 |
|
|
$ |
256.6 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Net earnings per common share from continuing operations: |
|
|
|
|
|
|
|
|||||||||
Basic |
$ |
0.48 |
|
|
$ |
0.49 |
|
|
$ |
0.94 |
|
|
$ |
0.76 |
|
|
Diluted |
$ |
0.48 |
|
|
$ |
0.48 |
|
|
$ |
0.93 |
|
|
$ |
0.76 |
|
|
Net earnings (loss) per share from discontinued operations: |
|
|
|
|
|
|
|
|||||||||
Basic |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(0.01 |
) |
|
Diluted |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(0.01 |
) |
|
Net earnings per share: |
|
|
|
|
|
|
|
|||||||||
Basic |
$ |
0.48 |
|
|
$ |
0.48 |
|
|
$ |
0.94 |
|
|
$ |
0.76 |
|
|
Diluted |
$ |
0.48 |
|
|
$ |
0.48 |
|
|
$ |
0.93 |
|
|
$ |
0.75 |
|
|
Average common stock and common equivalent shares outstanding: |
|
|
|
|
|
|
|
|||||||||
Basic |
|
357.4 |
|
|
|
339.4 |
|
|
|
358.3 |
|
|
|
339.0 |
|
|
Diluted |
|
359.8 |
|
|
|
342.4 |
|
|
|
364.2 |
|
|
|
342.1 |
|
|
The sum of net earnings per share amounts may not add due to rounding. |
This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).
FORTIVE CORPORATION AND SUBSIDIARIES |
||||||||||||||||
SEGMENT INFORMATION |
||||||||||||||||
(unaudited) |
||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Sales: |
|
|
|
|
|
|
|
|||||||||
Intelligent Operating Solutions |
$ |
630.1 |
|
|
$ |
541.8 |
|
|
$ |
1,217.7 |
|
|
$ |
1,052.7 |
|
|
Precision Technologies |
|
499.1 |
|
|
|
471.9 |
|
|
|
961.5 |
|
|
|
919.3 |
|
|
Advanced Healthcare Solutions |
|
334.1 |
|
|
|
306.0 |
|
|
|
660.6 |
|
|
|
606.9 |
|
|
Total |
$ |
1,463.3 |
|
|
$ |
1,319.7 |
|
|
$ |
2,839.8 |
|
|
$ |
2,578.9 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Operating Profit: |
|
|
|
|
|
|
|
|||||||||
Intelligent Operating Solutions |
$ |
129.9 |
|
|
$ |
115.3 |
|
|
$ |
236.9 |
|
|
$ |
223.4 |
|
|
Precision Technologies |
|
115.3 |
|
|
|
104.1 |
|
|
|
216.7 |
|
|
|
200.0 |
|
|
Advanced Healthcare Solutions |
|
28.1 |
|
|
|
22.5 |
|
|
|
56.1 |
|
|
|
41.4 |
|
|
Other (a) |
|
(24.8 |
) |
|
|
(30.6 |
) |
|
|
(48.9 |
) |
|
|
(55.9 |
) |
|
|
|
(16.2 |
) |
|
|
— |
|
|
|
(16.2 |
) |
|
|
— |
|
|
Total |
|
232.3 |
|
|
|
211.3 |
|
|
|
444.6 |
|
|
|
408.9 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Operating Margins: |
|
|
|
|
|
|
|
|||||||||
Intelligent Operating Solutions |
|
20.6 |
% |
|
|
21.3 |
% |
|
|
19.5 |
% |
|
|
21.2 |
% |
|
Precision Technologies |
|
23.1 |
% |
|
|
22.1 |
% |
|
|
22.5 |
% |
|
|
21.8 |
% |
|
Advanced Healthcare Solutions |
|
8.4 |
% |
|
|
7.4 |
% |
|
|
8.5 |
% |
|
|
6.8 |
% |
|
Total |
|
15.9 |
% |
|
|
16.0 |
% |
|
|
15.7 |
% |
|
|
15.9 |
% |
|
|
|
|
|
|
|
|
|
|||||||||
(a) Operating profit amounts in the Other category consist of unallocated corporate costs and other costs not considered part of our evaluation of reportable segment operating performance. |
This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).
FORTIVE CORPORATION AND SUBSIDIARIES |
||||||||
CONSOLIDATED BALANCE SHEETS |
||||||||
|
As of |
|||||||
|
|
|
|
|||||
|
(unaudited) |
|
|
|||||
ASSETS |
|
|
|
|||||
Current assets: |
|
|
|
|||||
Cash and equivalents |
$ |
682.9 |
|
|
$ |
819.3 |
|
|
Trade accounts receivable, net |
|
940.9 |
|
|
|
930.2 |
|
|
Inventories: |
|
|
|
|||||
Finished goods |
|
224.8 |
|
|
|
215.4 |
|
|
Work in process |
|
104.0 |
|
|
|
94.0 |
|
|
Raw materials |
|
218.9 |
|
|
|
203.3 |
|
|
Inventories |
|
547.7 |
|
|
|
512.7 |
|
|
Prepaid expenses and other current assets |
|
273.8 |
|
|
|
252.7 |
|
|
Total current assets |
|
2,445.3 |
|
|
|
2,514.9 |
|
|
|
|
|
|
|||||
Property, plant and equipment, net of accumulated depreciation of |
|
407.6 |
|
|
|
395.5 |
|
|
Other assets |
|
481.3 |
|
|
|
512.9 |
|
|
|
|
9,058.2 |
|
|
|
9,152.0 |
|
|
Other intangible assets, net |
|
3,678.5 |
|
|
|
3,890.2 |
|
|
Total assets |
$ |
16,070.9 |
|
|
$ |
16,465.5 |
|
|
|
|
|
|
|||||
LIABILITIES AND EQUITY |
|
|
|
|||||
Current liabilities: |
|
|
|
|||||
Current portion of long-term debt |
|
999.9 |
|
|
|
2,151.7 |
|
|
Trade accounts payable |
|
581.7 |
|
|
|
557.9 |
|
|
Accrued expenses and other current liabilities |
|
1,029.7 |
|
|
|
1,005.3 |
|
|
Total current liabilities |
|
2,611.3 |
|
|
|
3,714.9 |
|
|
|
|
|
|
|||||
Other long-term liabilities |
|
1,328.0 |
|
|
|
1,426.3 |
|
|
Long-term debt |
|
2,682.2 |
|
|
|
1,807.3 |
|
|
Commitments and Contingencies |
|
|
|
|||||
|
|
|
|
|||||
Equity: |
|
|
|
|||||
Preferred stock: |
|
— |
|
|
|
— |
|
|
Common stock: |
|
3.6 |
|
|
|
3.6 |
|
|
Additional paid-in capital |
|
3,651.2 |
|
|
|
3,670.0 |
|
|
|
|
(242.9 |
) |
|
|
— |
|
|
Retained earnings |
|
6,374.5 |
|
|
|
6,023.6 |
|
|
Accumulated other comprehensive loss |
|
(342.1 |
) |
|
|
(185.0 |
) |
|
Total |
|
9,444.3 |
|
|
|
9,512.2 |
|
|
Noncontrolling interests |
|
5.1 |
|
|
|
4.8 |
|
|
Total stockholders’ equity |
|
9,449.4 |
|
|
|
9,517.0 |
|
|
Total liabilities and equity |
$ |
16,070.9 |
|
|
$ |
16,465.5 |
|
This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).
FORTIVE CORPORATION AND SUBSIDIARIES |
||||||||
CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS |
||||||||
(unaudited) |
||||||||
|
Six Months Ended |
|||||||
|
|
|
|
|||||
Cash flows from operating activities: |
|
|
|
|||||
Net earnings from continuing operations |
$ |
338.1 |
|
|
$ |
293.7 |
|
|
Noncash items: |
|
|
|
|||||
Amortization |
|
192.1 |
|
|
|
155.0 |
|
|
Depreciation |
|
41.9 |
|
|
|
37.7 |
|
|
Stock-based compensation expense |
|
45.0 |
|
|
|
36.8 |
|
|
Loss on extinguishment of debt |
|
— |
|
|
|
104.2 |
|
|
Gain on investment in Vontier Corporation |
|
— |
|
|
|
(57.0 |
) |
|
Gain on litigation resolution |
|
— |
|
|
|
(26.0 |
) |
|
|
|
9.2 |
|
|
|
— |
|
|
Change in trade accounts receivable, net |
|
(37.7 |
) |
|
|
(11.8 |
) |
|
Change in inventories |
|
(50.7 |
) |
|
|
(24.0 |
) |
|
Change in trade accounts payable |
|
40.1 |
|
|
|
9.1 |
|
|
Change in prepaid expenses and other assets |
|
(39.2 |
) |
|
|
(21.4 |
) |
|
Change in accrued expenses and other liabilities |
|
(29.6 |
) |
|
|
(53.3 |
) |
|
Total operating cash provided by continuing operations |
|
509.2 |
|
|
|
443.0 |
|
|
Total operating cash used in discontinued operations |
|
— |
|
|
|
(18.7 |
) |
|
Net cash provided by operating activities |
|
509.2 |
|
|
|
424.3 |
|
|
|
|
|
|
|||||
Cash flows from investing activities: |
|
|
|
|||||
Cash paid for acquisitions, net of cash received |
|
(1.6 |
) |
|
|
0.9 |
|
|
Payments for additions to property, plant and equipment |
|
(37.1 |
) |
|
|
(17.1 |
) |
|
All other investing activities |
|
— |
|
|
|
1.1 |
|
|
Net cash used in investing activities |
|
(38.7 |
) |
|
|
(15.1 |
) |
|
|
|
|
|
|||||
Cash flows from financing activities: |
|
|
|
|||||
Payment of |
|
(1,156.5 |
) |
|
|
— |
|
|
Net proceeds from commercial paper borrowings |
|
481.3 |
|
|
|
— |
|
|
Proceeds from borrowings (maturities greater than 90 days), net of issuance costs of |
|
397.0 |
|
|
|
— |
|
|
Repayment of borrowings (maturities greater than 90 days) |
|
— |
|
|
|
(611.1 |
) |
|
Payment of common stock cash dividend to shareholders |
|
(50.0 |
) |
|
|
(47.4 |
) |
|
Payment of mandatory convertible preferred stock cash dividend to shareholders |
|
— |
|
|
|
(34.5 |
) |
|
Repurchase of common shares |
|
(242.9 |
) |
|
|
— |
|
|
All other financing activities |
|
(11.8 |
) |
|
|
25.2 |
|
|
Net cash used in financing activities |
|
(582.9 |
) |
|
|
(667.8 |
) |
|
|
|
|
|
|||||
Effect of exchange rate changes on cash and equivalents |
|
(24.0 |
) |
|
|
(0.4 |
) |
|
Net change in cash and equivalents |
|
(136.4 |
) |
|
|
(259.0 |
) |
|
Beginning balance of cash and equivalents |
|
819.3 |
|
|
|
1,824.8 |
|
|
Ending balance of cash and equivalents |
$ |
682.9 |
|
|
$ |
1,565.8 |
|
This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).
FORTIVE CORPORATION AND SUBSIDIARIES
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
AND OTHER INFORMATION
Adjusted Net Earnings from Continuing Operations and Adjusted Diluted Net Earnings per Share from Continuing Operations
We disclose the non-GAAP measures of historical adjusted net earnings from continuing operations and historical and forecasted adjusted diluted net earnings per share from continuing operations, which to the extent applicable, make the following adjustments to GAAP net earnings from continuing operations and GAAP diluted net earnings per share from continuing operations:
- Excluding on a pretax basis amortization of acquisition-related intangible assets;
- Excluding on a pretax basis acquisition and other transaction costs deemed significant (“Transaction Costs”);
-
Excluding on a pretax basis
Russia exit and wind down costs; - Excluding on a pretax basis the effect of inventory fair value adjustments related to significant acquisitions;
- Excluding on a pretax basis the effect of losses from our equity method investments;
- Excluding the pretax loss on debt extinguishment, net of non-recurring gain on our investment in Vontier common stock;
-
Excluding on a pretax basis the non-cash interest expense associated with our
0.875% convertible senior notes; - Excluding on a pretax basis the gain on litigation resolution;
- Excluding the tax effect (to the extent tax deductible) of the adjustments noted above. The tax effect of such adjustments was calculated by applying our overall estimated effective tax rate to the pretax amount of each adjustment (unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment). We expect to apply our overall estimated effective tax rate to each adjustment going forward;
- With respect to the adjusted diluted net earnings per share, included the impact of the assumed conversion of our Mandatory Convertible Preferred Stock at the beginning of the period; and
-
Including the actual cash interest expense on our
0.875% Senior Convertible Notes due 2022 (“Convertible Notes”) that was not included under the if-converted methodology mandated in 2022 and, with respect to the adjusted diluted net earnings per share, excluding the outstanding shares of common stock imputed under the in-converted methodology for the Convertible Notes that, in fact, were repaid and settled without issuance of any shares of common stock.
Acquisition and Divestiture Related Items
While we have a history of acquisition and divestiture activity, we do not acquire and divest of businesses and assets on a predictable cycle. The amount of an acquisition’s purchase price allocated to intangible assets and related amortization term and the inventory fair value adjustments are unique to each acquisition and can vary significantly from acquisition to acquisition. In addition, the Transaction Costs and non-recurring gain on disposition of assets are unique to each transaction, are impacted from period to period depending on the number of acquisitions or divestitures evaluated, pending, or completed during such period, and the complexity of such transactions. We adjust for, and identify as significant, Transaction Costs, acquisition related fair value adjustments to inventory, and corresponding restructuring charges primarily related to acquisitions, in each case, incurred in a given period, if we determine that such costs and adjustments exceed the range of our typical Transaction Costs and adjustments, respectively, in a given period. We believe, however, that it is important for investors to understand that such intangible assets contribute to revenue generation and that intangible assets and inventory fair value adjustments related to past acquisitions will recur in future periods until such intangible assets and inventory fair value adjustments, as applicable, have been fully amortized.
Equity Method Investments
We adjust for the effect of earnings and losses from our equity method investments over which we do not exercise control over the operations or the resulting earnings or losses. We believe that this adjustment provides our investors with additional insight into our operational performance. However, it should be noted that earnings and losses from our equity method investments will recur in future periods while we maintain such investments.
Gain on
On
On
Additionally, on
We adjust for the non-recurring effect of the gain on our investment in the Retained Vontier Shares and the corresponding loss on debt extinguishment because we believe that this adjustment facilitates comparison of our performance with prior and future periods and provides our investors with additional insight into our operational performance.
Mandatory Convertible Preferred Stock
In
For the purposes of calculating adjusted earnings and adjusted earnings per share in periods when the MCPS are anti-dilutive, we have excluded the MCPS dividend and, for the purposes of calculating adjusted earnings per share, assumed the “if-converted” method of share dilution and assumed the shares were converted at the beginning of the period (the incremental shares of common stock deemed outstanding applying the “if-converted” method of share dilution, the “MCPS Converted Shares”). We believe that using the “if-converted” method provides additional insight to investors on the potential impact of the MCPS had they been converted at the beginning of the period. For periods where the MCPS are dilutive, no such adjustment is made, as the “if-converted” method is applied and the assumed conversion is already included.
Gain on Litigation Resolution
Prior to our acquisition of ASP, Johnson & Johnson received a Civil Investigative Demand (“CID”) from the
Management had continually evaluated the likelihood and magnitude of the asserted claims based on new information that became available. In the second quarter of 2021, following the unsealing of the whistleblower lawsuit and DOJ’s declination to intervene in the litigation, the plaintiff dismissed the lawsuit. Based on these developments, management derecognized the litigation liability from our Consolidated Condensed Balance Sheet and recorded the gain on litigation resolution of
We adjust for the non-recurring effect of the gain on litigation resolution because we believe that this adjustment facilitates comparison of our performance with prior and future periods and provides our investors with additional insight into our operational performance.
Convertible Notes
On
Of the proceeds received from the issuance of the Convertible Senior Notes,
On
Russia Ukraine Conflict
In connection with the invasion of
As a result of the exit of our business operations in
Management believes that each of the non-GAAP financial measures noted above provide useful information to investors by reflecting additional ways of viewing aspects of our operations that, when reconciled to the corresponding GAAP measure, help our investors to understand the long-term profitability trends of our business, and facilitate comparisons of our operational performance and profitability to prior and future periods and to our peers.
These non-GAAP measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measures, and may not be comparable to similarly titled measures reported by other companies.
Core Revenue Growth
We use the term “core revenue growth” when referring to a corresponding year-over-year GAAP revenue measure, excluding (1) the impact from acquired businesses and (2) the impact of currency translation. References to sales attributable to acquisitions or acquired businesses refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition and the effect of purchase accounting adjustments, less the amount of sales attributable to certain divested businesses or product lines not considered discontinued operations prior to the first anniversary of the divestiture. The portion of sales attributable to the impact of currency translation is calculated as the difference between (a) the period-to-period change in sales (excluding sales impact from acquired businesses) and (b) the period-to-period change in sales (excluding sales impact from acquired businesses) after applying the current period foreign exchange rates to the prior year period. This non-GAAP measure should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.
Management believes that this non-GAAP measure provides useful information to investors by helping identify underlying growth trends in our business and facilitating comparisons of our revenue performance with prior and future periods and to our peers. We exclude the effect of acquisition and divestiture-related items because the nature, size and number of such transactions can vary dramatically from period to period and between us and our peers. We exclude the effect of currency translation from sales measures because currency translation is not under management’s control and is subject to volatility. We believe that such exclusions, when presented with the corresponding GAAP measures, may assist in assessing the business trends and making comparisons of long-term performance.
Free Cash Flow
We use the term “free cash flow” when referring to cash provided by operating activities calculated according to GAAP less payments for additions to property, plant, and equipment.
Management believes that such non-GAAP measure provides useful information to investors in assessing our ability to generate cash without external financing, fund acquisitions and other investments and, in the absence of refinancing, repay our debt obligations. However, it should be noted that free cash flow as a liquidity measure has material limitations because it excludes certain expenditures that are required or that we have committed to, such as debt service requirements and other non-discretionary expenditures. Such non-GAAP measure should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.
Adjusted Net Earnings From Continuing Operations
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||
($ in millions) |
|
|
|
|
|
|
|
|||||||||
Net Earnings Attributable to Common Stockholders from Continuing Operations (GAAP) (a) |
$ |
173.0 |
|
|
$ |
164.8 |
|
|
$ |
338.1 |
|
|
$ |
259.2 |
|
|
Dividends on the mandatory convertible preferred stock to apply if-converted method (a) |
|
— |
|
|
|
17.2 |
|
|
|
— |
|
|
|
34.5 |
|
|
Net Earnings from Continuing Operations (GAAP) |
$ |
173.0 |
|
|
$ |
182.0 |
|
|
$ |
338.1 |
|
|
$ |
293.7 |
|
|
Interest on the Convertible Notes to apply if-converted method (b) |
|
— |
|
|
|
— |
|
|
|
2.1 |
|
|
|
— |
|
|
Tax effect of the Convertible Notes to apply if-converted method (c) |
|
— |
|
|
|
— |
|
|
|
(0.3 |
) |
|
|
— |
|
|
Diluted Net Earnings from Continuing Operations (GAAP) |
|
173.0 |
|
|
|
182.0 |
|
|
|
339.9 |
|
|
|
293.7 |
|
|
Pretax amortization of acquisition-related intangible assets |
|
95.7 |
|
|
|
77.5 |
|
|
|
192.1 |
|
|
|
155.0 |
|
|
Pretax acquisition and other transaction costs |
|
8.1 |
|
|
|
3.6 |
|
|
|
15.6 |
|
|
|
9.4 |
|
|
Pretax Russia exit and wind down costs |
|
16.2 |
|
|
|
— |
|
|
|
16.2 |
|
|
|
— |
|
|
Pretax acquisition-related fair value adjustments to inventory related to significant acquisitions |
|
0.3 |
|
|
|
1.2 |
|
|
|
0.7 |
|
|
|
6.7 |
|
|
Pretax losses from equity method investments |
|
3.1 |
|
|
|
4.0 |
|
|
|
5.7 |
|
|
|
6.6 |
|
|
Pretax loss on debt extinguishment, net of gain on Vontier common stock |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
47.9 |
|
|
Pretax non-cash interest expense associated with our |
|
— |
|
|
|
7.1 |
|
|
|
— |
|
|
|
14.8 |
|
|
Pretax interest expense on Convertible Notes to reverse if-converted method (b) |
|
— |
|
|
|
— |
|
|
|
(2.1 |
) |
|
|
— |
|
|
Pretax gain on litigation resolution |
|
— |
|
|
|
(26.0 |
) |
|
|
— |
|
|
|
(26.0 |
) |
|
Tax effect of the adjustments reflected above (c) |
|
(15.3 |
) |
|
|
(10.6 |
) |
|
|
(32.0 |
) |
|
|
(40.2 |
) |
|
Adjusted Net Earnings from Continuing Operations (Non-GAAP) |
$ |
281.1 |
|
|
$ |
238.8 |
|
|
$ |
536.1 |
|
|
$ |
467.9 |
|
|
|
|
|
|
|
|
|
|
|||||||||
(a) On |
||||||||||||||||
(b) Beginning with our adoption of ASU 2020-06 on |
||||||||||||||||
(c) The dividend on the MCPS is not tax deductible and the convertible note interest is calculated on a net of tax basis and therefore the tax effect of the adjustments includes only the amortization of acquisition-related intangible assets, acquisition and other transaction costs, acquisition-related fair value adjustments to inventory, losses from equity method investments, the loss on extinguishment of debt, the non-cash interest expense associated with the |
Adjusted Diluted Net Earnings Per Share from Continuing Operations
|
Three Months Ended(a) |
|
Six Months Ended(a) |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net Earnings Attributable to Common Stockholders from Continuing Operations (GAAP) (b) |
$ |
0.48 |
|
|
$ |
0.48 |
|
|
$ |
0.93 |
|
|
$ |
0.76 |
|
|
Dividends on the mandatory convertible preferred stock to apply if-converted method (b) |
|
— |
|
|
|
0.05 |
|
|
|
— |
|
|
|
0.10 |
|
|
Assumed dilutive impact on the Diluted Net Earnings Per Share Attributable to Common Stockholders if the MCPS Converted Shares had been outstanding (b) |
|
— |
|
|
|
(0.03 |
) |
|
|
— |
|
|
|
(0.05 |
) |
|
Net Earnings Per Share from Continuing Operations (GAAP) |
|
0.48 |
|
|
|
0.50 |
|
|
|
0.93 |
|
|
|
0.81 |
|
|
Interest on the Convertible Notes to apply if-converted method (c) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Tax effect of the Convertible Notes to apply if-converted method (c) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Diluted Net Earnings Per Share from Continuing Operations (GAAP) |
|
0.48 |
|
|
|
0.50 |
|
|
|
0.93 |
|
|
|
0.81 |
|
|
Pretax amortization of acquisition-related intangible assets |
|
0.27 |
|
|
|
0.21 |
|
|
|
0.53 |
|
|
|
0.43 |
|
|
Pretax acquisition and other transaction costs |
|
0.02 |
|
|
|
0.01 |
|
|
|
0.04 |
|
|
|
0.03 |
|
|
Pretax Russia exit and wind down costs |
|
0.05 |
|
|
|
— |
|
|
|
0.04 |
|
|
|
|||
Pretax acquisition-related fair value adjustments to inventory related to significant acquisitions |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.02 |
|
|
Pretax losses from equity method investments |
|
0.01 |
|
|
|
0.01 |
|
|
|
0.02 |
|
|
|
0.02 |
|
|
Pretax loss on debt extinguishment, net of gain on Vontier common stock |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.13 |
|
|
Pretax non-cash interest expense associated with our |
|
— |
|
|
|
0.02 |
|
|
|
— |
|
|
|
0.04 |
|
|
Pretax gain on litigation resolution |
|
— |
|
|
|
(0.07 |
) |
|
|
— |
|
|
|
(0.07 |
) |
|
Pretax interest on Convertible Notes to reverse if-converted method (c) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Tax effect of the adjustments reflected above (d) |
|
(0.05 |
) |
|
|
(0.03 |
) |
|
|
(0.08 |
) |
|
|
(0.11 |
) |
|
Adjusted Diluted Net Earnings Per Share from Continuing Operations (Non-GAAP) |
$ |
0.78 |
|
|
$ |
0.66 |
|
|
$ |
1.49 |
|
|
$ |
1.30 |
|
|
|
|
|
|
|
|
|
|
|||||||||
(a) The |
||||||||||||||||
(b) Prior to their conversion on |
||||||||||||||||
(c) Beginning with our adoption of ASU 2020-06 on |
||||||||||||||||
(d) The dividend on the MCPS is not tax deductible and the convertible note interest is calculated on a net of tax basis and therefore the tax effect of the adjustments includes only the amortization of acquisition-related intangible assets, acquisition and other transaction costs, acquisition-related fair value adjustments to inventory, losses from equity method investments, the loss on extinguishment of debt, the non-cash interest expense associated with the |
||||||||||||||||
The sum of the components of adjusted diluted net earnings per share from continuing operations may not equal due to rounding. |
Adjusted Diluted Shares Outstanding
|
Three Months Ended |
|
Six Months Ended |
||||||
(shares in millions) |
|
|
|
|
|
|
|
||
Average common diluted stock outstanding |
359.8 |
|
342.4 |
|
364.2 |
|
|
342.1 |
|
MCPS Converted Shares (a) |
— |
|
19.2 |
|
— |
|
|
19.2 |
|
Convertible Notes - if converted shares (b) |
— |
|
— |
|
(3.2 |
) |
|
— |
|
Adjusted average common stock and common equivalent shares outstanding |
359.8 |
|
361.6 |
|
361.0 |
|
|
361.3 |
|
|
|
|
|
|
|
|
|
||
(a) Prior to their conversion on |
|||||||||
(b) Beginning with our adoption of ASU 2020-06 on |
Core Revenue Growth
|
% Change Three
|
|
% Change Six Months
|
|||
Total Revenue Growth (GAAP) |
10.9 |
% |
|
10.1 |
% |
|
Core (Non-GAAP) |
8.9 |
% |
|
7.1 |
% |
|
Acquisitions (Non-GAAP) |
5.0 |
% |
|
5.3 |
% |
|
Impact of currency translation (Non-GAAP) |
(3.0 |
) % |
|
(2.3 |
) % |
Free Cash Flow From Continuing Operations
($ in millions) |
Three Months Ended |
|
|
|
Six Months Ended |
|
|
|||||||||||||||
|
|
|
|
|
%
|
|
|
|
|
%
|
||||||||||||
Operating Cash Flows from Continuing Operations (GAAP) |
$ |
294.4 |
|
|
$ |
291.0 |
|
|
1.2 |
% |
|
$ |
509.2 |
|
$ |
443.0 |
|
|
14.9 |
% |
||
Less: purchases of property, plant & equipment (capital expenditures) from continuing operations (GAAP) |
|
(18.4 |
) |
|
|
(8.7 |
) |
|
|
|
|
(37.1 |
) |
|
(17.1 |
) |
|
|
||||
Free Cash Flow from Continuing Operations (Non-GAAP) |
$ |
276.0 |
|
|
$ |
282.3 |
|
|
(2.3 |
) % |
|
$ |
472.1 |
|
$ |
425.9 |
|
|
10.9 |
% |
Forecasted Adjusted Diluted Net Earnings Per Share from Continuing Operations
|
Three Months Ending
|
|
Twelve Months Ending
|
|||||||||||||
|
Low End |
|
High End |
|
Low End |
|
High End |
|||||||||
Forecasted Net Earnings Per Share from Continuing Operations (GAAP) |
$ |
0.49 |
|
|
$ |
0.53 |
|
|
$ |
2.03 |
|
|
$ |
2.09 |
|
|
Anticipated pretax amortization of acquisition-related intangible assets |
|
0.27 |
|
|
|
0.27 |
|
|
|
1.06 |
|
|
|
1.06 |
|
|
Anticipated pretax significant acquisition and other transaction costs |
|
0.02 |
|
|
|
0.02 |
|
|
|
0.07 |
|
|
|
0.07 |
|
|
Anticipated pretax |
|
— |
|
|
|
— |
|
|
|
0.05 |
|
|
|
0.05 |
|
|
Anticipated pretax losses from equity method investments |
|
— |
|
|
|
— |
|
|
|
0.02 |
|
|
|
0.02 |
|
|
Tax effect of the adjustments reflected above |
|
(0.05 |
) |
|
|
(0.05 |
) |
|
|
(0.16 |
) |
|
|
(0.16 |
) |
|
Forecasted Adjusted Diluted Net Earnings Per Share from Continuing Operations |
$ |
0.74 |
|
|
$ |
0.77 |
|
|
$ |
3.07 |
|
|
$ |
3.13 |
|
|
|
|
|
|
|
|
|
|
|||||||||
The impact of interest expense on Convertible Notes to reverse the if-converted method rounds to zero for the three months ending |
||||||||||||||||
The sum of the components of forecasted adjusted diluted net earnings per share from continuing operations may not equal due to rounding. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005392/en/
Investor Relations
Telephone: (425) 446-5000
Source:
FAQ
What were Fortive's Q2 2022 earnings results?
What is Fortive's revenue outlook for 2022?
How much did Fortive adjust its EPS forecast for 2022?
What charge did Fortive incur in Q2 2022?